COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,883 Articles (22,568 medRxiv, 8,315 bioRxiv)

Most recent first Previous |  Page 5: Articles 41-50  | Next

Bivalent mRNA booster encoding virus-like particles elicits potent polyclass RBD antibodies in pre-vaccinated mice
Fan, C., Cohen, A. A., Dam, K.-M. A., Rorick, A. V., Priso Fils, A.-C. I., Yang, Z., Gnanapragasam, P. N., Segovia, L. N., Huey-Tubman, K. E., Moon, W. J., Lin, P. J., Bjorkman, P. J., Hoffmann, M. A.
10.1101/2025.08.18.670983 — Posted: 2025-08-19
SARS-CoV-2 S protein activates the HIV latent reservoir through the mTOR pathway
Xu, L., Shi, H., Chen, L., Wang, H., Shi, H., Miao, X., Li, S., Jiang, Y.
10.1101/2025.08.18.670887 — Posted: 2025-08-19
Persistent Immune Dysregulation during Post-Acute Sequelae of COVID-19 is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins
Kwissa, M., Mathayan, M., Salunkhe, S. S., Bakthavachalam, V., Ye, Z., Sanborn, M. A., Condo, S., Upadhye, A., Nemakal, A., Richner, J. M., Basu, S., Novak, R. M., Jacobson, J. R., Ganesh, B. B., Cerda, M., Utz, P. J., Krishnan, J. A., Prabhakar, B. S., Rehman, J.
10.1101/2025.08.18.670908 — Posted: 2025-08-19
CBM KG: A Comorbidity-Centric Knowledge Graph Uncovering Causal Pathomechanisms Between COVID-19 and Neurodegenerative Diseases
Atas Guvenilir, H., Sethumadhavan, P., Kaladharan, A., Vieira de Sa, R., Sridhar, A., Haferkamp, U., Pless, O., Marti-Sarrias, A., Acosta, S., Letoha, T., Hudak, A., Ohnmacht, J., Hefeng, F. Q., Hofmann-Apitius, M., Tom Kodamullil, A.
10.1101/2025.08.18.670790 — Posted: 2025-08-19
A Super-Resolution Spatial Atlas of SARS-CoV-2 Infection in Human Cells
Andronov, L., Han, M., Balaji, A., Zhu, Y., Qi, L. S., Moerner, W. E.
10.1101/2025.08.15.670620 — Posted: 2025-08-18
Metatranscriptomic Insights into Host-Microbiome Interactions Underlying Asymptomatic COVID-19 Cases
Chowdhury, S. F., Sarkar, M. H., Al Sium, S. M., Naser, S. R., Hossain, M. S., Habib, M. A., Akter, S., Banu, T. A., Goswami, B., Jahan, I., Chakrovarty, T., Molla, M. M. A., Nafisa, T., Yeasmin, M., Ghosh, A. K., Khan, M. S.
10.1101/2025.08.18.670804 — Posted: 2025-08-18
Dose-dependent interferon programs in myeloid cells after mRNA and adenovirus COVID-19 vaccination
Eryilmaz, G. N., Yazici, Y. Y., Ucar, D., Banchereau, J., Kuchel, G. A., Garcia-Sastre, A., Schotsaert, M., Jangra, S., Handrjek, K., Kenyon-Pesce, L., Marches, R., Mimitou, E. P.
10.1101/2025.08.15.668720 — Posted: 2025-08-18
Machine-learning strategy for high error tolerance in image-based digital molecular assays
McAffee, D. B., Hu, Q., Arnob, A., Wu, H.-J., Groves, J. T.
10.1101/2025.08.14.670347 — Posted: 2025-08-18
Modeling the Dynamics of COVID-19: Model With Patients With Underlying Conditions.
Magak, G. O., Kagunda, J., Ronoh, M.
10.1101/2025.08.14.25332881 — Posted: 2025-08-16
Changes in Pediatric RSV Hospitalizations after the COVID-19 Pandemic, 2022-2023, Canada: An Active Surveillance Study
Lopes, A., Embree, J., Jadavji, T., Kazmi, K., Langley, J. M., Lebel, M. H., Le Saux, N., Moore, D., Morris, S. K., Pernica, J. M., Robinson, J., Sadarangani, M., Shulha, H., Bettinger, J., Papenburg, J.
10.1101/2025.08.13.25333142 — Posted: 2025-08-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).